原料辞典検索/behentrimonium-chloride/BEHENTRIMONIUM CHLORIDE
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
合成 (Synthetic)

BEHENTRIMONIUM CHLORIDE

標準 INCI 準拠: BEHENTRIMONIUM CHLORIDE
帯電防止剤ヘアコンディショニング剤防腐剤
[EU CosIng Official Definition] Behentrimonium Chloride is the quaternary ammonium salt that conforms to the formula:
結論先行 エグゼクティブ規制・安全性ファクトボックスAEO / GEO CITATION ANCHOR

化粧品における BEHENTRIMONIUM CHLORIDE のグローバル配合基準と処方特性とは?

BEHENTRIMONIUM CHLORIDE(CAS番号: 17301-53-0)は、化粧品処方において主に帯電防止剤, ヘアコンディショニング剤, 防腐剤として配合される原料です。日本厚労省/JCIA(規制なし)、韓国MFDS(配合制限)、欧州CosIng(配合制限)など6大法域の法定基準下で管理され、通常 0.5–3%(適正安定域 pH 4–8)で処方されます。

7大トラック 国別・用途別 公式全成分表示名称マトリクス

各国公的告示原典のみ収録 · 機械翻訳・任意音訳ゼロ
7-Track Official Statutory Label Names for BEHENTRIMONIUM CHLORIDE
法域・規制トラック公式全成分表示名称ワンクリックコピー
① 韓国 (MFDS 化粧品標準名称)BEHENTRIMONIUM CHLORIDE (KR MFDS Registered)
② 韓国旧名称履歴 (301 リダイレクト)Former KR Nomenclature Redirect Active—
③ 欧州連合 (EU CosIng EC 1223/2009)BEHENTRIMONIUM CHLORIDE
④ 米国一般化粧品 (US PCPC / MoCRA INCI)BEHENTRIMONIUM CHLORIDE
⑤ 米国 FDA OTC モノグラフ有効成分名— (米国 OTC 対象外 / 一般化粧品原料)—
⑥ 中国 (NMPA IECIC 標準中国語名称)山嵛基三甲基氯化铵
⑦ 日本化粧品表示名称 / 医薬部外品外原規名称 (JCIA / MHLW)BEHENTRIMONIUM CHLORIDE (標準INCI参照 · 任意カタカナ音訳排除)

Layer 1 — 6大法域 法定配合上限および規制ステータス

Layer 1 Statutory Regulatory Limits Across 6 Regions for BEHENTRIMONIUM CHLORIDE
法域規制ステータス配合上限制限条件および一次法源出典
韓国 (MFDS)配合制限GMP公的化粧品原料目録収載 (GMP基準内使用)
欧州 (EU)配合制限GMP公的化粧品原料目録収載 (GMP基準内使用)
米国 (FDA)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
中国 (NMPA)配合可能GMPIECIC Entry #5956
日本 (MHLW)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
ASEAN (ACD)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)

Layer 2 — 毒性・安全性評価上限 (US CIR / EU SCCS / CN IECIC)

「欧州 SCCS 安全性評価上限」は消費者安全科学委員会が安全域 (MoS≥100) と判定した毒性学的上限であり、「米国 CIR 市販製品最大報告濃度」および「中国 IECIC 最高歴史使用量」は市販製品における最大実績濃度です。

Layer 2 Toxicological & Historical Safe Use Concentrations for BEHENTRIMONIUM CHLORIDE
安全性評価基準適用範囲・用途安全濃度範囲判定結果および文献参照
米国 CIR 市販製品最大報告濃度hair0.2~7%安全判定 (MoS≥100)115_draft_trimon.pdf ()
米国 CIR 市販製品最大報告濃度spray0.2~1%安全判定 (MoS≥100)115_draft_trimon.pdf ()
米国 CIR 市販製品最大報告濃度rinse_off3~3%安全判定 (MoS≥100)115_draft_trimon.pdf ()
米国 CIR 市販製品最大報告濃度hair_dye2~3%安全判定 (MoS≥100)115_draft_trimon.pdf ()
米国 CIR 市販製品最大報告濃度dermal0.5~0.9%安全判定 (MoS≥100)115_draft_trimon.pdf ()
欧州 SCCS 安全性評価上限 (MoS≥100)rinse_off≤ 5%安全判定 (MoS≥100) ()
欧州 SCCS 安全性評価上限 (MoS≥100)leave_on≤ 3%安全判定 (MoS≥100) ()
⚠️ 参考用案内 (免責事項): 本辞典の成分名・規制上限・処方ガイドは研究開発の参考用です。法改正の時差やデータの誤記・漏れがあり得るため、実際の処方・ラベル表示・届出前には必ず管轄当局の最新告示原文をご確認ください。本情報の利用により生じた問題について運営主体は法的責任を負いません。
Interactive Quartile Box-Plot (Min–Q1–Median–Q3–Max)

Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit

Rinse-off Cleansern=16
Min 0.5% · Q1 1% · Median 2.175% · Q3 2.5% · Max 3%
Emulsion / Creamn=10
Min 0.5% · Q1 1.45% · Median 1.475% · Q3 2.9% · Max 3%
Rinse-off Cleanser — Rinse-off cleanser & surfactant system modifier
Verified Source: Global Starter Formulation Library Statistical Distribution (n=16, EVONIK 11 · GRANT 4 · SEPPIC 1) (cir_safety) · EVONIK 11 · GRANT 4 · SEPPIC 1
Typical Median: 2.175%

Layer 3 — 剤形別通常配合濃度 (四分位数 n≥5) & 物理化学・相溶性ガイド

Layer 3 Formulation Concentration Quartiles by Product Category for BEHENTRIMONIUM CHLORIDE
剤形グループMin – Q1 – Median – Q3 – Max (%)処方役割・作用機序Source ID
剤形群 C — 洗い流し用クレンザー・シャンプー0.5% · 1% · 2.175% · 2.5% · 3%Rinse-off cleanser & surfactant system modifierGlobal Starter Formulation Library Statistical Distribution (n=16, EVONIK 11 · GRANT 4 · SEPPIC 1)
剤形群 B — 乳液・エマルジョン・クリーム0.5% · 1.45% · 1.475% · 2.9% · 3%Emulsion cream & lotion structural / conditioning agentGlobal Starter Formulation Library Statistical Distribution (n=10, GRANT 10)
Cutaneous Permeation Science (500 Dalton Rule)MW: Macro/Complex · LogP: N/A

Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery

Stratum Corneum (Brick & Mortar Barrier · 10–20 µm)500 Da Molecular Weight Cutoff BarrierViable Epidermis (Keratinocytes & Melanocytes · 50–100 µm)Target for Brightening (Tyrosinase/Melanosome) & Barrier LipidsPapillary Dermis (Fibroblasts & ECM Collagen · 150–300 µm)Target for Collagen I/III Synthesis, Peptides, PDRN & ExosomesEpidermal Passive Permeation (<500 Da)
Molecular Weight & LogP Permeation Diagnosis
Low Molecular Weight (320 Da ≤ 500 Da) — Passive Permeation Feasible

Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.

Estimated Target Depth
40–90 µm
Optimal Delivery System
Polyol Enhancer / Serum
Colloid Interface, pH Spectrum & Thermal Stability

pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior

Water or glycol phase soluble/dispersible
Optimal Formulation pH Stability Window (0–14)pH 4.0 – 8.0
0245.5791114

Outside pH 4–8, risk of hydrolysis, viscosity loss, or ionic dissociation increases.

Maximum Thermal Processing Limit (°C)≤ 50°C
25°C45°C60°C75°C85°C100°C

Thermally stable up to 50°C during standard emulsification.

HLB Scale (0–20) & Colloidal Micelle / Lamellar Phase Simulator
O/W Oil-in-Water Micelle Emulsion (Lotion / Cream)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
Biochemical Signaling & Mechanism Pathway

Cellular & Molecular Target Mechanism Flow

1. Epidermal Interaction→ Upregulation / Activation
Intercellular Lipid & Hydration Matrix
→
TEWL Reduction & Barrier Conditioning
2. Homeostasis Modulation⊣ Inhibition / Blockade
Oxidative Stress (ROS) & Irritant Cascade
⊣
Cutaneous Soothing & Homeostasis
Formulation Ontology Radial Graph

Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)

+ GLYCERIN+ CAPRYLIC/CAPRIC TR…+ TOCOPHEROL✕ Verify phase compati…BEHENTRIMONIUM CHL…
Interactive Node Guide

Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.

代表商品名参考 (商標法第90条第1項第2号 記述的表示)
BEHENTRIMONIUM CHLORIDE

商品名は研究者がグレードを識別するための参考表記であり、各商標権は原メーカーに帰属します。

学術・毒性・処方統合モノグラフ

Tier 1 Synthesis

本原料に紐づく NIH PubMed 査読付き論文アブストラクトおよび公的毒性評価報告書のみに基づいて作成された学術要約です。

■ [1. Chemical Identity & International Labeling Nomenclature] - INCI Name: BEHENTRIMONIUM CHLORIDE | CAS No.: 17301-53-0 | EC No.: 241-327-0 - Origin: SYNTHETIC | Functions: , , - Physicochemical Profile: Formula | MW /(Polymer/Complex) | / | Ionic Nature: non-ionic | CosIng/MFDS - Official Regional Label Names: US [BEHENTRIMONIUM CHLORIDE] · EU [BEHENTRIMONIUM CHLORIDE] · CN [山嵛基三甲基氯化铵] · JP [-] · JP Quasi-Drug [-] ■ [2. Dermatological Mechanism of Action & Functional Role] - Behentrimonium Chloride is the quaternary ammonium salt that conforms to the formula: Classified under origin 'synthetic', it acts within the cosmetic vehicle or stratum corneum to deliver , , performance and structural formulation stability. ■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)] - Regional Summary: KR: RESTRICTED | EU: RESTRICTED | US: NONE | CN: ALLOWED | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. 5956 (山嵛基三甲基氯化铵)) - [EU / COMPOSITION / limited] (Max 5%): - [EU / COMPOSITION / limited] (Max 0.1%): - [KR / COMPOSITION / limited] (Max 5%): - Official Safety & Historical Use Concentration (Layer 2): cir (reported_use, hair): 0.2~7% / cir (reported_use, spray): 0.2~1% / cir (reported_use, rinse_off): 3~3% ■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)] - [cleanser_rinse] Typical range: 0.5 ~ 3.0% (Median 2.175%, Ref: Global Starter Formulation Library Statistical Distribution (n=16, EVONIK 11 · GRANT 4 · SEPPIC 1)) — Rinse-off cleanser & surfactant system modifier - [emulsion_cream] Typical range: 0.5 ~ 3.0% (Median 1.475%, Ref: Global Starter Formulation Library Statistical Distribution (n=10, GRANT 10)) — Emulsion cream & lotion structural / conditioning agent ■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)] - Addition Phase: Water Phase or Cool-down Phase (< 45°C) - Optimal pH Range: pH 4.0 ~ 8.0 | Max Process Temp: Max 50°C | Electrolyte Tolerance: MEDIUM - Incompatibility / Caution: Verify phase compatibility under extreme pH or high electrolyte loads - Synergy Pairings: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | Reference Trade Names: BEHENTRIMONIUM CHLORIDE ■ [6. Peer-Reviewed Literature & Official Compendia Evidence] - PMID 41126531 (2026, Int J Cosmet Sci): Electrokinetic analysis reveals common conditioner ingredient interactions with human hair - PMID 33811764 (2021, Int J Cosmet Sci): Investigation of the interactions of cationic guar with human hair by electrokinetic analysis - PMID 24064305 (2013, Toxicol In Vitro): Confirmation of in vitro and clinical safety assessment of behentrimonium chloride-containing leave-on body lotions usin

関連査読付き学術論文 (NIH PubMed) (4)

Electrokinetic analysis reveals common conditioner ingredient interactions with human hair [PMID: 41126531 · 2026]
Tham HP, Yip KY, Luxbacher T, McMullen RL, Dawson TL · Int J Cosmet Sci (2026)

This study aims to use electrokinetic analysis to investigate the deposition behaviour and conditioning efficacy of cationic surfactants on human hair, focusing on how surfactant structure, concentration and hair damage influence performance. It also aims to understand the mechanisms governing surfactant adsorption and their impact on hair manageability and health. This research employed streaming potential measurements-including pH-dependent, time-dependent and concentration-dependent zeta (&#x3b6;)-potential studies-alongside wet combing analyses and ATR-FTIR spectroscopy to evaluate the adsorption affinity and conditioning effects of four cationic surfactants: behentrimonium chloride (BTMC), behentrimonium methosulfate (BTMS), hexadecyltrimethylammonium chloride (CTAC) and stearylalkonium chloride (STAC). A simplified model surface using silicon oxide (Si | SiO 2 ) wafers was also utilized to isolate the influence of hair's natural variability and fibrous structure. Longer-chain surfactants like BTMC showed superior deposition and conditioning due to stronger van der Waals interactions, while bulky groups in STAC hindered deposition. BTMC outperformed BTMS, likely due to the chloride counterion's higher mobility. BTMC and BTMS were superior against CTAC and STAC due to their longer carbon chain length. Wet combing analyses revealed that BTMC significantly reduced combing forces, improving manageability, whereas STAC fared the worst due to its low adsorption. However, ATR-FTIR analysis indicated no reversal of oxidative damage, suggesting conditioners improve manageability without repairing structural damage. The study highlights the importance of surfactant molecular structure-such as carbon chain length and counterion type-in deposition efficiency and conditioning performance, providing valuable insights for developing more effective hair care formulations. By leveraging electrokinetic analyses in the form of streaming potential experiments, we were able to quantitatively assess adsorption behaviour, &#x3b6;-potential changes and the dynamic interactions between surfactants and hair. These findings enhance the understanding of cationic surfactant-hair interactions, offering practical implications for optimizing conditioners to improve user experience and hair health. Cette &#xe9;tude vise &#xe0; utiliser une analyse &#xe9;lectrocin&#xe9;tique pour &#xe9;valuer le comportement de d&#xe9;p&#xf4;t et l'efficacit&#xe9; de conditionnement des tensioactifs cationiques sur les cheveux humains, en se concentrant sur la fa&#xe7;on dont la structure et la concentration des tensioactifs et le degr&#xe9; de dommage capillaire influencent les performances. Elle vise &#xe9;galement &#xe0; comprendre les m&#xe9;canismes qui r&#xe9;gissent l'adsorption des tensioactifs et leur impact sur la facilit&#xe9; de coiffage et la sant&#xe9; des cheveux. M&#xc9;THODES: Cette recherche a utilis&#xe9; des mesures du potentiel de diffusion (&#xe9;tudes de potentiel z&#xea;ta [&#x3b6;] en fonction du pH, du temps et de la concentration), ainsi que des analyses de peignage humide et une spectroscopie ATR&#x2010;FTIR pour &#xe9;valuer l'affinit&#xe9; d'adsorption et les effets de conditionnement de quatre tensioactifs cationiques: chlorure de b&#xe9;hentrimonium (BTMC), m&#xe9;thosulfate de b&#xe9;hentrimonium (BTMS), chlorure d'hexad&#xe9;cyltrim&#xe9;thylammonium (CTAC) et chlorure de st&#xe9;aralkonium (STAC). Un mod&#xe8;le de surface simplifi&#xe9; utilisant des plaquettes d'oxyde de silicium (Si |SiO 2 ) a &#xe9;galement &#xe9;t&#xe9; utilis&#xe9; pour isoler l'influence de la variabilit&#xe9; naturelle des cheveux et de la structure de la fibre capillaire. R&#xc9;SULTATS: Les tensioactifs &#xe0; longue cha&#xee;ne, comme le BTMC, ont montr&#xe9; un d&#xe9;p&#xf4;t et un conditionnement sup&#xe9;rieurs en raison d'interactions de Van der Waals plus fortes, tandis que les groupes volumineux en STAC ont limit&#xe9; le d&#xe9;p&#xf4;t. Le BTMC a surp

Investigation of the interactions of cationic guar with human hair by electrokinetic analysis [PMID: 33811764 · 2021]
McMullen RL, Laura D, Zhang G, Kroon B · Int J Cosmet Sci (2021)

Cationic guar is an important polysaccharide used as a hair conditioning agent in personal care products. In this article, we report streaming potential data demonstrating its behaviour as it interacts electrostatically with hair. Several cationic guar variants with different molecular weights (MWs) and charge densities (CDs) were examined. All experiments were carried out with a custom-designed streaming potential instrument so that in situ, real-time data were monitored during the treatment of a hair plug with aqueous solutions of cationic guar and subsequent treatment with anionic surfactants-sodium laureth sulfate (SLES) and cocamidopropyl betaine (CAPB)-commonly found in contemporary shampoo formulations. The MW of the cationic guar variants plays an integral role in determining the thickness of the adsorbed polymer layer on the hair surface while CD influences the zeta potential. Data were also generated for the treatment of hair with a cationic flexible polymer (polyquaternium-28) and cationic conditioning surfactant (behentrimonium chloride) to provide a frame of reference. The deposition behaviour on hair of high MW cationic guar variants is distinct from these conventional molecules in terms of its electrokinetic properties. We also examined the electrokinetic behaviour of cationic guar on hair types from different racial backgrounds. While the cationic guar treatment yielded similar results for the different hair types, anionic surfactant treatment resulted in quicker sorption and desorption from African, European 65% grey, and Mulatto hair as compared to Chinese, European dark brown, and Indian hair. We introduce an in situ technique for measuring the dynamic sorption/desorption of charged molecules on the surface of human hair. Evaluation of a series of cationic guar species revealed varying behaviour depending on the MW and CD of the polysaccharide. Our data also demonstrate differences in the desorption properties of typical shampoo surfactants for hair from diverse racial backgrounds. Le guar cationique est un polysaccharide important utilis&#xe9; comme conditionneur capillaire dans les produits cosm&#xe9;tiques. Dans ce rapport, nous d&#xe9;montrons l'utilisation de la technique du potentiel de streaming pour &#xe9;tudier comment le guar cationique interagit &#xe9;lectrostatiquement avec les cheveux. Plusieurs variantes del guar cationique avec diff&#xe9;rents poids mol&#xe9;culaires et densit&#xe9;s de charge ont &#xe9;t&#xe9; examin&#xe9;s. M&#xc9;THODES: Nous avons utilis&#xe9; un instrument de potentiel de streaming pour les exp&#xe9;riences. Les &#xe9;tudes ont &#xe9;t&#xe9; r&#xe9;alis&#xe9;es en temps r&#xe9;el pour surveiller le traitement de cheveu avec des solutions aqueuses de guar cationique suivi d'un traitement ult&#xe9;rieur avec tensioactifs anioniques comment le sulfate de laureth de sodium et le cocamidopropyle b&#xe9;ta&#xef;ne, des ingr&#xe9;dients g&#xe9;n&#xe9;ralement trouv&#xe9;s dans les formulations de shampooing. R&#xc9;SULTATS: Le poids mol&#xe9;culaire des variants du guar cationique joue un r&#xf4;le int&#xe9;gral dans la d&#xe9;termination l'&#xe9;paisseur de la couche de polym&#xe8;re adsorb&#xe9;e sur la surface des cheveux tandis que le densit&#xe9; de charge influence le potentiel z&#xea;ta. Des donn&#xe9;es ont &#xe9;galement &#xe9;t&#xe9; g&#xe9;n&#xe9;r&#xe9;es pour le traitement des cheveux avec un polym&#xe8;re flexible (polyquaternium-28) et tensioactif de conditionnement cationique (behentrimonium chlorure) pour fournir un cadre de r&#xe9;f&#xe9;rence. Le comportement de d&#xe9;p&#xf4;t sur les cheveux des variants de guar cationiques &#xe0; poids mol&#xe9;culaire &#xe9;lev&#xe9; est distinct de ces mol&#xe9;cules conventionnelles en termes de ses propri&#xe9;t&#xe9;s &#xe9;lectrocin&#xe9;tiques. Nous avons &#xe9;galement examin&#xe9; le comportement &#xe9;lectrocin&#xe9;tique de guar cationique sur des types de cheveux de diff&#xe9;rents milieux raciaux. Le traitement

Confirmation of in vitro and clinical safety assessment of behentrimonium chloride-containing leave-on body lotions using post-marketing adverse event data. [PMID: 24064305 · 2013]
Cameron DM, Donahue DA, Costin GE, Kaufman LE, Avalos J, Downey ME, Billhimer WL, Gilpin S, Wilt N, Simion FA · Toxicol In Vitro (2013)

Behentrimonium chloride (BTC) is a straight-chain alkyltrimonium chloride compound commonly used as an antistatic, hair conditioning, emulsifier, or preservative agent in personal care products. Although the European Union recently restricted the use of alkyltrimonium chlorides and bromides as preservatives to &#x2264;0.1%, these compounds have been safely used for many years at &#x2264;5% in hundreds of cosmetic products for other uses than as a preservative. In vitro, clinical, and controlled consumer usage tests in barrier-impaired individuals were conducted to determine if whole body, leave-on skin care products containing 1-5% BTC cause dermal irritation or any other skin reaction with use. BTC-containing formulations were predicted to be non-irritants by the EpiDerm&#xae; skin irritation test and the bovine corneal opacity and permeability (BCOP)/chorioallantoic membrane vascular assay (CAMVA) ocular irritation test battery. No evidence of allergic contact dermatitis or cumulative dermal irritation was noted under the exaggerated conditions of human occlusive patch tests. No clinically assessed or self-reported adverse reactions were noted in adults or children with atopic, eczematous, and/or xerotic skin during two-week and four-week monitored home usage studies. These results were confirmed by post-marketing data for five body lotions, which showed only 0.69 undesirable effects (mostly skin irritation) reported per million shipped consumer units during 2006-2011; a value consistent with a non-irritating body lotion. No serious undesirable effects were reported during in-market use of the products. Therefore, if formulated in appropriate conditions at 1-5%, BTC will not cause dermal irritation or delayed contact sensitization when used in a whole-body, leave-on product.

Repeatability of Quantitative Diffusion-Weighted Imaging Metrics in Phantoms, Head-and-Neck and Thyroid Cancers: Preliminary Findings [PMID: 30854438 · 2019]
Paudyal R, Konar AS, Obuchowski NA, Hatzoglou V, Chenevert TL, Malyarenko DI, Swanson SD, LoCastro E, Jambawalikar S, Liu MZ, Schwartz LH, Tuttle RM, Lee N, Shukla-Dave A · Tomography (2019)

The aim of this study was to establish the repeatability measures of quantitative Gaussian and non-Gaussian diffusion metrics using diffusion-weighted imaging (DWI) data from phantoms and patients with head-and-neck and papillary thyroid cancers. The Quantitative Imaging Biomarker Alliance (QIBA) DWI phantom and a novel isotropic diffusion kurtosis imaging phantom were scanned at 3 different sites, on 1.5T and 3T magnetic resonance imaging systems, using standardized multiple b-value DWI acquisition protocol. In the clinical component of this study, a total of 60 multiple b-value DWI data sets were analyzed for test-retest, obtained from 14 patients (9 head-and-neck squamous cell carcinoma and 5 papillary thyroid cancers). Repeatability of quantitative DWI measurements was assessed by within-subject coefficient of variation (wCV%) and Bland-Altman analysis. In isotropic diffusion kurtosis imaging phantom vial with 2% ceteryl alcohol and behentrimonium chloride solution, the mean apparent diffusion (D app &#xd7; 10 -3 mm 2 /s) and kurtosis (K app , unitless) coefficient values were 1.02 and 1.68 respectively, capturing in vivo tumor cellularity and tissue microstructure. For the same vial, D app and K app mean wCVs (%) were &#x2264;1.41% and &#x2264;0.43% for 1.5T and 3T across 3 sites. For pretreatment head-and-neck squamous cell carcinoma, apparent diffusion coefficient, D, D*, K, and f mean wCVs (%) were 2.38%, 3.55%, 3.88%, 8.0%, and 9.92%, respectively; wCVs exhibited a higher trend for papillary thyroid cancers. Knowledge of technical precision and bias of quantitative imaging metrics enables investigators to properly design and power clinical trials and better discern between measurement variability versus biological change.

よくある質問 (FAQ)

Q1. BEHENTRIMONIUM CHLORIDE の各国公式全成分表示名称(7トラック)はどのように異なりますか?
日本化粧品工業連合会(JCIA)表示名称は 'BEHENTRIMONIUM CHLORIDE (標準INCI準拠)'、米国PCPC・欧州CosIng INCIは 'BEHENTRIMONIUM CHLORIDE'、中国NMPA IECIC標準中国語名は '山嵛基三甲基氯化铵' です。
Q2. BEHENTRIMONIUM CHLORIDE のグローバル6大法域における法定配合基準 (Layer 1) は?
6大法域規制ステータス — 日本(JP): none、韓国(KR): restricted、欧州(EU): restricted、米国(US): none、中国(CN): allowed、ASEAN: none。
Q3. 処方設計における BEHENTRIMONIUM CHLORIDE の通常配合濃度 (Layer 3) と適正 pH は?
主要剤形 (cleanser_rinse) において通常 0.5〜3%(中央値 2.175%)で配合され、適正pH範囲は 4〜8 です。
Q4. BEHENTRIMONIUM CHLORIDE の配合禁忌 (Incompatibilities) と推奨シナジー成分は?
推奨シナジーペアは GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL、配合上の注意点は Verify phase compatibility under extreme pH or high electrolyte loads です。